| A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis RL Greenman, RMH Schein, MA Martin, RP Wenzel, NR Maclntyre, ... Jama 266 (8), 1097-1102, 1991 | 952 | 1991 |
| Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs D Sun, H Lennernas, LS Welage, JL Barnett, CP Landowski, D Foster, ... Pharmaceutical research 19, 1400-1416, 2002 | 485 | 2002 |
| Prevention of stress ulceration: current trends in critical care RJ Daley, JA Rebuck, LS Welage, FB Rogers Critical care medicine 32 (10), 2008-2013, 2004 | 270 | 2004 |
| Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases LS Welage, RR Berardi Journal of the American Pharmaceutical Association (1996) 40 (1), 52-62, 2000 | 265 | 2000 |
| Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells YY Chiu, K Higaki, BL Neudeck, JL Barnett, LS Welage, GL Amidon Pharmaceutical research 20, 749-756, 2003 | 130 | 2003 |
| Consumers' views on generic medications CA Gaither, DM Kirking, FJ Ascione, LS Welage Journal of the American Pharmaceutical Association (1996) 41 (5), 729-736, 2001 | 127 | 2001 |
| Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters CP Landowski, D Sun, DR Foster, SS Menon, JL Barnett, LS Welage, ... Journal of Pharmacology and Experimental Therapeutics 306 (2), 778-786, 2003 | 111 | 2003 |
| Pharmacologic properties of proton pump inhibitors LS Welage Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (10P2 …, 2003 | 100 | 2003 |
| Alterations in gastric acidity in patients infected with human immunodeficiency virus LS Welage, PL Carver, S Revankar, C Pierson, CA Kauffman Clinical infectious diseases 21 (6), 1431-1438, 1995 | 94 | 1995 |
| Understanding the scientific issues embedded in the generic drug approval process LS Welage, DM Kirking, FJ Ascione, CA Gaither Journal of the American Pharmaceutical Association (1996) 41 (6), 856-867, 2001 | 85 | 2001 |
| Human jejunal permeability of two polar drugs: cimetidine and ranitidine N Takamatsu, ON Kim, LS Welage, NM Idkaidek, Y Hayashi, J Barnett, ... Pharmaceutical research 18, 742-744, 2001 | 74 | 2001 |
| Human intestinal permeability of piroxicam, propranolol, phenylalanine, and PEG 400 determined by jejunal perfusion N Takamatsu, LS Welage, NM Idkaidek, DY Liu, PID Lee, Y Hayashi, ... Pharmaceutical research 14, 1127-1132, 1997 | 66 | 1997 |
| Pharmacokinetics of ceftazidime in patients with renal insufficiency LS Welage, RW Schultz, JJ Schentag Antimicrobial agents and chemotherapy 25 (2), 201-204, 1984 | 65 | 1984 |
| Historical overview of generic medication policy. FJ Ascione, DM Kirking, CA Gaither, LS Welage Journal of the American Pharmaceutical Association (Washington, DC: 1996) 41 …, 2001 | 62 | 2001 |
| Mechanistic understanding of time-dependent oral absorption based on gastric motor activity in humans K Higaki, SY Choe, R Löbenberg, LS Welage, GL Amidon European journal of pharmaceutics and biopharmaceutics 70 (1), 313-325, 2008 | 59 | 2008 |
| Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motility N Takamatsu, LS Welage, Y Hayashi, R Yamamoto, JL Barnett, VP Shah, ... European journal of pharmaceutics and biopharmaceutics 53 (1), 37-47, 2002 | 57 | 2002 |
| Overview of pharmacologic agents for acid suppression in critically ill patients LS Welage American journal of health-system pharmacy 62 (10_Supplement_2), S4-S10, 2005 | 55 | 2005 |
| Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration. NA Mason, BL Neudeck, LS Welage, JA Patel, RD Swartz Clinical nephrology 60 (2), 96-104, 2003 | 48 | 2003 |
| Proton Pump Inhibitor Formulary Considerations in the Acutely III: Part 1: Pharmacology, Pharmacodynamics, and Available Formulations JW Devlin, LS Welage, KM Olsen Annals of Pharmacotherapy 39 (10), 1667-1677, 2005 | 42 | 2005 |
| Determinants of antibiotic‐associated hypoprothrombinemia JJ Schentag, LS Welage, TH Grasela, MH Adelman Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 7 (3), 80-86, 1987 | 42 | 1987 |
